SCHEMBL4978488

SCHEMBL4978488

Cc1cc(Cl)cc2c1NC(=O)C21NC(=O)N(Cc2ccc(C(F)(F)F)cc2)C1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.41
HSP90AA1 P07900 1/20 0.39
USP2 O75604 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TP53 P04637 1/20 0.39
POLB P06746 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
ALOX15 P16050 1/20 0.39
MAPK1 P28482 1/20 0.39
HSD17B10 Q99714 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
HTT P42858 2/20 0.37
CHRM5 P08912 4/20 0.37
CHRM3 P20309 1/20 0.37
P2RX3 P56373 1/20 0.36
PTGDR2 Q9Y5Y4 2/20 0.36
PPARG P37231 1/20 0.35
PPARD Q03181 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4255809 0.82 CHRM5 (0.39) ARHSP90AA1CHRM5CHRM3P2RX3
SCHEMBL23390599 0.82 MAPT (0.42) ARUSP2ALDH1A1TP53POLB
SCHEMBL3951185 0.81 ALDH1A1 (0.37) ARUSP2ALDH1A1TP53POLB
SCHEMBL4978483 0.78 P2RX3 (0.38) HSP90AA1USP2ALDH1A1TP53POLB
SCHEMBL3953341 0.75 MAPT (0.40) USP2ALDH1A1TP53POLBGAA
Azd1386 SCHEMBL4257077 0.73 SMN1; SMN2 (0.45) TP53MAPTSMN1; SMN2HTT
SCHEMBL4260823 0.72 HSP90AA1 (0.52) HSP90AA1ALDH1A1TP53MAPTSMN1; SMN2
SCHEMBL4260128 0.71 AR (0.52) AR
SCHEMBL4257016 0.71 PTGDR2 (0.35) PTGDR2
SCHEMBL4159776 0.70 CNR1 (0.39) PPARDCNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1984374-A1 USE OF SPIRO Ý IMIDAZOLIDINE-4, 3'-INDOLE¨2, 2', 5' (1H) TRIONES FOR TREATMENT OF CONDITIONS ASSOCIATED WITH VANILLOID RECEPTOR 1 AstraZeneca AB (SE) 2008-10-29 EP claimed
WO-2007091946-A1 USE OF SPIRO [ IMIDAZOLIDINE-4, 3'-INDOLE] 2, 2', 5' (1H) TRIONES FOR TREATMENT OF CONDITIONS ASSOCIATED WITH VANILLOID RECEPTOR 1 ASTRAZENECA AB (SE) 2007-08-16 WO claimed